Voyager Recruits Patients for Phase 1 Trial Testing VY-AADC01 Gene Therapy Delivery – Parkinson’s News Today
|
Voyager Recruits Patients for Phase 1 Trial Testing VY-AADC01 Gene Therapy Delivery
Parkinson’s News Today Voyager Therapeutics announced it’s recruiting participants for the company’s new Phase 1 clinical trial to test a new approach for their gene therapy VY-AADC01 in Parkinson’s disease patients. The company has also released updates to its ongoing Phase … |
|
Voyager Recruits Patients for Phase 1 Trial Testing VY-AADC01 Gene Therapy Delivery
Parkinson’s News Today Voyager Therapeutics announced it’s recruiting participants for the company’s new Phase 1 clinical trial to test a new approach for their gene therapy VY-AADC01 in Parkinson’s disease patients. The company has also released updates to its ongoing Phase … |
|
Journal for ImmunoTherapy of Cancer Highlights New Single Cell Bioinformatics Tools From IsoPlexis Used To …
PR Newswire (press release) Researchers from IsoPlexis and Novartis published the results from their collaboration in the November issue of the Journal for ImmunoTherapy of Cancer. IsoCode, IsoPlexis’ next-generation platform developed to detect cellular responses at the single … |